Download Free Medical GERD and Its Supraesophageal or Extraesophageal Manafestations PowerPoint Presentation

GERD and Its Supraesophageal or Extraesophageal Manafestations PowerPoint Presentation

DOWNLOAD MEDICAL POWERPOINT PRESENTATION

About This Presentation

Description : A condition that occurs when the lower esophageal sphincter (LES) does not close properly and stomach contents leak back, or reflux, into the esophagus.

Tags : GERD,gastroesophageal reflux disease,prevalence of GERD,symptoms of GERD,disorders in GERD,sleep apnea

Published on : Sep 06, 2022 | Views : 961 | Downloads : 19

Shareable Url :

Embed Code :

Comment

Transcript

Slide 1-

GERD and itssupraesophageal or extraesophageal manafestations Yousif A. Qari Ass.prof,Consultant Gastroenterologist KAUH
Slide 2-

What is GERD A condition that occurs when the lower esophageal sphincter (LES) does not close properly and stomach contents leak back, or reflux, into the esophagus. The LES is a ring of muscle at the bottom of the esophagus that acts like a valve between the esophagus and stomach.
Slide 3-

Prevalence of GERD Approximately 20% of adults have frequent "classic" symptoms of gastroesophageal reflux (GER): Heartburn Regurgitation.
Slide 4-

What causes GERD? No one knows why people get GERD. A hiatal hernia may contribute.
Slide 5-

Other factors that may contribute to GERD Alcohol use Overweight Pregnancy Smoking
Slide 6-

Certain foods can be associated with reflux events Citrus fruits Chocolate Drinks with caffeine Fatty and fried foods Garlic and onions Mint flavorings Spicy foods Tomato-based foods, like spaghetti sauce, chili, and pizza
Slide 7-

What are the symptoms of GERD Persistent heartburn and acid regurgitation. Belching Waterbrash (sudden excess of saliva) Sour taste in the mouth Food stuck in throat Difficulty or pain when swallowing Chest pain Hoarseness Choking or throat tightness. Chronic sore throat Dry cough Bad breath Inflammation of the gums Erosion of tooth enamel (the surface of the teeth)
Slide 8-

How is GERD diagnosed? Review of symptoms and a complete physical examination, with Special attention to alarming symptoms. Duration & severity of symptoms Anemia Dysphagia (Difficulty in swollowing) Weight loss
Slide 9-

Diagnosis of supraesophageal Reflux Heartburn and regurgitation many of these patients fail to demonstrate the typical symptoms of heartburn and regurgitation The response of symptoms to an empirical trial of antireflux therapy Ambulatory, esophageal pH monitoring Upper gastrointestinal endoscopy Most do not have esophagitis when looked at endoscopically.
Slide 10-

A normal upper esophagoscopy
Slide 11-

The Los Angeles Classification System for the endoscopic assessment of reflux oesophagitis GRADE A: One or more mucosal breaks no longer than 5 mm, non of which extends between the tops of the mucosal folds
Slide 12-

The Los Angeles Classification System for the endoscopic assessment of reflux oesophagitis GRADE B: One or more mucosal breaks more than 5 mm long, none of which extends between the tops of two mucosal folds
Slide 13-

The Los Angeles Classification System for the endoscopic assessment of reflux oesophagitis GRADE C: Mucosal breaks that extend between the tops of two or more mucosal folds, but which involve less than 75% of the oesophageal circumference
Slide 14-

The Los Angeles Classification System for the endoscopic assessment of reflux oesophagitis GRADE D: Mucosal breaks which involve at least 75% of the oesophageal circumference
Slide 15-

Endoscopic view of GERD complications
Slide 16-

ppt slide no 16 content not found
Slide 17-

Limitations of esophsgeal pH monitoring Not accepted by patients easily Optimal site of probe placement (ie, pharyngeal vs upper esophageal) What is a normal vs abnormal amount of acid reflux. False-negatives may occur A positive test does not prove a causative relationship to the symptoms Normal pH testing in the upper and lower esophagus is strong evidence against acid-related symptoms Nonacidic reflux may also play a pathophysiologic role in the symptoms of some patients (which may only resolve with fundoplication
Slide 18-

Catheter-Free pH-Monitoring System BRAVO Catheter-Free ph Testing Bravo can be placed during endoscopy Allows 24-hour or 48-hour pH monitoring to record more clinical data Patients maintain normal diet and routine activities Minimizes throat and nasal discomfort associated with transnasal catheters Transmits data to pager-sized reciever Uploads easily to pH analysis software C, DeMeester T, Peters J, et al. Clinical evaluation of the BRAVOTM probe - a catheter-free ambulatory esophageal pH monitoring system. Gastroenterology. 2001;120:A-35. [Abstract #177]
Slide 19-

Catheter-Free pH-Monitoring System In a controlled study of only 7 asymptomatic subjects the small amounts of measured acid reflux appeared comparable to that obtained with the conventional pH probe. Additional head-to-head trials of the micro-probe and conventional catheter systems are needed in symptomatic patients to determine the accuracy, reliability, and patient acceptance of this technique.
Slide 20-

How is GERD treated? Lifestyle Changes Medications Surgery Endoscopic options
Slide 21-

Lifestyle Changes If you smoke, stop. Do not drink alcohol. Lose weight if needed. Eat small meals. Wear loose-fitting clothes. Avoid lying down for 3 hours after a meal. Raise the head of your bed 6 to 8 inches by putting blocks of wood under the bedposts--just using extra pillows will not help.
Slide 22-

Medications Antacids: Maalox, Mylanta Pepto-Bismol Rolaids Foaming agents Gaviscon H2 blockers Cimetidine (Tagamet ) Famotidine (Pepcid) Nizatidine (Axid) Ranitidine (Zantac 75) Magnesium salt can lead to diarrhea, and aluminum salts can cause constipation
Slide 23-

Medications Proton pump inhibitors omeprazole (Prilosec) lansoprazole (Prevacid) pantoprazole (Protonix) rabeprazole (Aciphex) esomeprazole (Nexium) Prokinetics Bethanechol (Urecholine) Metoclopramide (Primpran) Domperidone (Motilium)
Slide 24-

Surgery Nissen Fundoplication
Slide 25-

Nissen Fundoplication
Slide 26-

Endoscopic view of Nissen Fundoplication
Slide 27-

Long-term complications of GERD? Inflammation of the esophagus Bleeding or ulcers strictures Barrett's esophagus and adenoarcinoma Supraesphageal manafestations Asthma chronic cough pulmonary fibrosis ENT manafestations
Slide 28-

Endoscopic pictures of GERD
Slide 29-

Extraesophageal disorders in GERD Extraesophageal manifestations of gastroesophageal reflux disorder (GERD) are frequent, and consist broadly of Noncardiac chest pain pulmonary diseases Asthma chronic cough recurrent bronchitis sleep apnea pulmonary fibrosis laryngeal diseases Laryngitis subglottic stenosis laryngeal cancer other ENT (ear, nose, throat) disorders Sinusitis Otitis media Pharyngitis dental erosion
Slide 30-

Noncardiac chest pain is associated with GERD Among patients with angina-like chest pain 30% will have normal coronary arteries; of these, 40% to 50% have objective evidence of GERD by endoscopy or ambulatory pH monitoring Prevalence of GERD symptoms is 23% to 100% Esophagitis is seen in 0% to 47% Abnormal ambulatory pH recordings noted in 20% to 63% Empiric trial of PPI 78% sensitivity and 86% specificity , for diagnosing GERD association with noncardiac chest pain.
Slide 31-

GERD and Chronic Cough Direct mucosal injury and/or Triggering vagally mediated mechanisms Increased airway secretions Bronchospasm
Slide 32-

Nonacid Gastroesophageal Reflux Reflux of gastric contents Food Nonacidic material. Symptoms that fail to respond to aggressive therapy with proton-pump inhibitors may still improve after antireflux surgery Traditional pH testing (which detects reductions in intraesophageal pH from a baseline of pH 6-7) cannot detect nonacidic reflux.
Slide 33-

Nonacid Gastroesophageal Reflux Nonacidic reflux was seen in both normal (healthy controls) subjects and GERD patients Measured by multichannel intraluminal impedance (MII) monitoring Accounted for one third of all reflux events Occurred more commonly after meals and in recumbency Only 4% of nonacidic reflux events were due to bile reflux Three fourths of bile reflux episodes occurred in conjunction with acid reflux Compared with acid reflux events, nonacidic reflux typically did not extend as far proximally and was cleared more quickly from the esophagus.
Slide 34-

importance of nonacidic reflux The true importance of nonacidic reflux in the pathogenesis of both esophageal and extraesophageal symptoms remains to be established. may be a factor in: Functional heartburn (ie, heartburn with normal esophageal pH measurements) Nonerosive reflux disorders Extraesophageal disorders, whose symptoms persist despite aggressive proton-pump inhibitor therapy. MII may be used to test for nonacidic reflux
Slide 35-

GERD and Chronic Cough The mechanisms remain controversial. Microaspiration Stimulation of a vagally mediated esophageal-bronchial reflex. That may also involve brainstem centers.
Slide 36-

GERD and Chronic Cough Establishing a definite cause-and-effect relationship between GER and chronic cough is difficult. A normal esophageal pH study argues against acid GER as a cause of chronic cough An abnormal pH study does not prove that acid reflux is the cause of chronic cough. Only a minority of patients with proven GER have improvement of cough after proton-pump inhibitor therapy.
Slide 37-

GERD and Chronic Cough Empirical trial of high-dose therapy with PPI Uncontrolled trials 70% to 100% improvement The only published placebo-controlled trial reported 35% response rate.
Slide 38-

GERD and Chronic Cough 75 patients with chronic cough prospectively evaluated GER symptoms in 72% abnormal pH testing in 56% (42 of 75) 20/42 had minimal or no reflux symptoms. Omeprazole was given to a subset of patients (n = 55) with either GER symptoms and/or abnormal pH testing. After 3-6 months, significant improvement was noted 45% No symptom or pH parameter was predictive of improvement. Garrigues V, Bastida G, Bau I, et al. Gastroenterology. 2001;120:A-430. [Abstract #2195]
Slide 39-

GERD and Chronic Cough Conclusions ambulatory esophageal pH testing still is of limited utility in the evaluation of patients with chronic cough. A normal pH study with a low SI (symptom index) , probably excludes acid-related cough, but a positive pH study does not prove a causal relationship. Many clinicians may choose to treat all patients with chronic cough with an empirical trial of high-dose proton-pump inhibitors (eg, omeprazole 40 mg twice daily), even if symptoms of reflux are absent. Cough usually responds within 2 weeks of therapy. An empirical trial is more cost-effective than formal evaluation with manometry and pH testing.
Slide 40-

Laryngopharyngeal reflux 81% will have a normal-appearing esophagus 40% may have symptoms of heartburn Symptoms consistent with this diagnosis Dysphonia Globus sensation Throat clearing Halitosis Sore throat Cough. Hoarseness is a majer coplaint in 92% of patients with GERD-related laryngitis > 50% of patients presenting to ENT specialists with hoarsness will have a component of GERD contributing to their symptoms
Slide 41-

Reflux Laryngitis Posterior laryngitis at laryngoscopy is a typical finding of reflux laryngitis Niether laryngoscopic findings nor positive pH studies have been found to be of predictive value in identifying patients likely to respond to proton-pump inhibitors. No agreement as to the optimal site of pharyngeal probe placement or normal values of esophagopharyngeal reflux (EPR). EPR is also is detected in up to 20% of normal controls.
Slide 42-

Reflux Laryngitis Study involved 62 cadidates 19 healthy controls 43 patients with suspected reflux laryngitis 17 with symptoms but a normal ENT exam 26 with posterior laryngitis. Videolaryngoscopy was performed in all subjects Dual-probe pH testing was performed, with the proximal probe located 1 cm above the upper esophageal sphincter in the pharynx. Pharyngeal acid reflux occurred in 26% of controls 53% patients with ENT symptoms alone 69% in patients with ENT symptoms and findings of posterior laryngitis However, there was no difference in symptoms between patients with abnormal and normal pH values, or between patients with an abnormal or normal-appearing larynx. Ylitalo R et al , Gastroenterology. 2001;120:A-426. [Abstract #2175]
Slide 43-

Reflux Laryngitis 49 patients with chronic ENT symptoms and abnormal laryngoscopic examination underwent a questionnaire and dual-probe esophageal (not pharyngeal) pH testing. After initial evaluation, patients were treated in an uncontrolled fashion with either high-dose proton-pump inhibitors high-dose proton-pump-inhibitor therapy and bedtime ranitidine. At 4 months, improvement was noted in 32 of 49 (65%) of patients treated with proton-pump inhibitors (with or without ranitidine). Symptoms, ENT findings, and pH parameters were not predictive of response to proton-pump inhibitor therapy. Vaezi M et al. Gastroenterology. 2001;120:A-118. [Abstract #636]
Slide 44-

ppt slide no 44 content not found
Slide 45-

Management of suspected reflux-laryngitis Increase dose / consider surgery Richter Gasroenterol clin north Am 1996 : 25; 75 Refer patient for 24h pH-metry on PPI therapy The laryngoscopic finding of "posterior laryngitis"
Slide 46-

Reflux Laryngitis Conclusions lack of predictive value for Symptoms ENT findings pH testing In uncontrolled trials, improvement is seen in 60% to 90% of selected patients. The efficacy, optimal dose, and duration of proton-pump inhibitors for reflux laryngitis have not been established in controlled trials.
Slide 47-

Other GERD-Associated ENT conditions Subglottic stenosis laryngeal carcinoma Globus Otitis media Sleep apnea Proving a cause-and-effect relationship between GER and these conditions is difficult.
Slide 48-

GER in Otitis Media GER may cause chronic otitis media Reflux of gastric contents into the nasopharynx and middle ear might precipitate infections and/or chronic effusions. Assessed 50 middle-ear effusions for pepsin and pepsinogen levels using an enzyme-linked immunosorbent assay (ELISA). Pepsin and pepsinogen were detected in 41 of 50 effusions (82%) provocative observation, but proof of causation is lacking. Tasker A, et al. Gastroenterology. 2001;120:A-119. [Abstract #638]
Slide 49-

GER and Sleep Apnea Obstructive sleep apnea (OSA) A condition that occurs as a result of the loss of normal pharyngeal muscle tone while sleeping, which allows the pharynx to collapse during inspiration. It is most common in: Obese anatomically narrowed upper airways due to macroglossia, micrognathia redundant pharyngeal or tonsillar soft tissue. Strong association between OSA and GER was suggested
Slide 50-

GER and Sleep Apnea 101 patients undergoing sleep studies for suspected OSA were evaluated for symptoms of GER Sleep apnea was diagnosed in 71 of 101 patients GER symptoms: 50% in patients with OSA 33% in patients without OSA. GER symptoms were not related to the severity of OSA. Guda N, et al .Gastroenterology. 2001;120:A-429. [Abstract #2190]
Slide 51-

GER and Sleep Apnea Coclusions Observations so far do not prove symptom causality. Patients with OSA may be predisposed to GER Obesity sedentary lifestyle alcohol use smoking. Obstructed breathing patterns (with negative intrathoracic pressure) also may predispose to GER A controlled trial of GER therapy in patients with OSA is needed. Patients with OSA should be assessed for GER symptoms pre- and post-OSA treatment.
Slide 52-

ppt slide no 52 content not found
Slide 53-

ppt slide no 53 content not found
Slide 54-

ppt slide no 54 content not found
Slide 55-

Coclusions Gastroesophageal reflux is extremely common and may manifest with typical and atypical symptoms. At present it is extremely difficult to establish a definite diagnosis of extraesophageal GERD. Typical esophageal symptoms (heartburn, regurgitation) may be absent in a large number of patients. Neither the type of ENT symptoms nor the ENT findings are of predictive value in determining underlying GER.
Slide 56-

Coclusions Although interesting new modalities for reflux testing are available (capsule pH monitoring, impedance testing) it remains to be seen whether these modalities improve diagnostic accuracy Currently, the most cost-effective approach for most patients with suspected reflux-related symptoms is a trial of a high-dose proton-pump inhibitor for 3 monthes. pH testing reserved to confirm adequate acid suppression in those with refractory symptoms. Although improvement in cough symptoms may be evident within 2 weeks of treatment, improvement in other ENT disorders may require 3 or more months of therapy. The place of Fundoplication is yet to be defined
Slide 57-

Thank you
Slide 58-

Diagnosis The majority of patients with extraesophageal manifestations of GER do not have the classic symptoms of heartburn or regurgitation less than 30% have endoscopic evidence of reflux esophagitis Twenty-four-hour pH monitoring has been commonly used to look for evidence of acid reflux into the lower esophagus, upper esophagus, and pharynx. However, this test is not comfortable for most patients
Slide 59-

GER and Sleep Apnea 41 consecutive patients with suspected OSA undergoing sleep exams were prospectively evaluated with a GERD symptom questionnaire. 22/41 enrolled patients, reported heartburn or acid regurgitation. 17/22 patients with heartburn reported that this symptom awakened them at night. Regression analysis suggested that GER severity was correlated to the apnea-hypoventilation index.